Prostate cancer Board decisions

The Board has determined that additional records are needed and a VA examination is required to determine the etiology of various disabilities, including MRSA, legal blindness, gout, lower back disability, left knee, right knee disability, memory loss, prostate cancer, lymphoma, and bilateral hammer toes. The Veteran's claims for compensation under 38 U.S.C. § 1151 for MRSA are also remanded.

The Board has determined that the Veteran's prostate cancer is at least as likely as not related to his exposure to carcinogens while stationed at Camp Lejeune during his active service, and thus grants service connection for prostate cancer.

The Board has remanded the cases for additional medical opinions regarding service connection for prostate cancer and malignant neoplasms of soft tissue (pelvis). The opinions are needed to address whether these conditions are related to the Veteran's reported exposure to paint fumes and dust on munitions during his active service.

The Veteran's residuals of prostate cancer are rated at 60 percent effective January 1, 2017.

The Veteran's prostate cancer residuals, post radiation therapy, do not warrant a rating in excess of 10 percent.,The Veteran's erectile dysfunction does not meet the criteria for a compensable disability rating.,The Veteran's PTSD symptoms do not meet the criteria for an initial disability rating in excess of 50 percent.

The Board has remanded the Veteran's claims of service connection for prostate cancer, diabetes mellitus type II, and peripheral neuropathy due to his exposure to herbicide agents/Agent Orange during his military service in Korea.

The Board denied service connection for diabetes mellitus type II and prostate cancer, finding no evidence of exposure to herbicide agents or actual exposure during the appellant's service. The diseases were not shown as chronic in service, nor are there established continuity of symptomatology.

The Veteran's prostate cancer was not incurred in or aggravated by service, and the Board denied his claim for service connection.

The Veteran's claim for an effective date prior to August 12, 2018, for the award of service connection for prostate cancer is denied. The earliest possible effective date under VA regulations is assigned as the date VA received his intent to file a claim on August 12, 2018.

The Veteran's claim for service connection for prostate cancer is denied as there is no evidence of herbicide agent or ionizing radiation exposure during service, and the medical opinion does not support a link between his current condition and service.

The Board has remanded the claims of service connection for sleep apnea, unspecified bipolar and related disorder, and prostate cancer due to potential exposure to Agent Orange during military service. The Veteran is also being asked to provide more information about his specific dates of service at Travis AFB and Elmendorf AFB.

The Board has granted service connection for prostate cancer, finding that it is a medically unexplained chronic multi-symptom illness (MUCMI) associated with exposure to burn pits during active duty.

The Board has remanded the Veteran's claims for service connection due to inadequate opinions in his VA examinations and incomplete development of stressor allegations. The claims will be reconsidered after these issues are addressed.

The Board has remanded several issues related to service connection for various disabilities, including a right eye disability, prostate cancer, brain tumor, and neuropathy of the upper and lower extremities. The Veteran's claims are being reviewed due to his assertions regarding exposure to jet fuel (JP-4 and JP-8) during service.

The Board has determined that the case must be remanded due to incomplete radiation exposure evaluation, and thus service connection for prostate cancer cannot be decided at this time.

The Veteran's claims for service connection for residuals of prostate cancer and erectile dysfunction as secondary to prostate cancer are being remanded due to insufficient information about his claimed Vietnam service.

The Board has granted service connection for prostate cancer, erectile dysfunction as secondary to prostate cancer, and Parkinson's disease. The Veteran was exposed to herbicide agents during his service at Udorn Royal Thai Air Force Base in Thailand due to his military occupational specialty and barracks location.

The Veteran's prostate cancer is presumed to be due to herbicide exposure in service, and the claim for service connection is granted.

The Board has restored the 100% evaluation for service-connected residuals of prostate cancer, effective from September 1, 2015.,The award of special monthly compensation (SMC) under 38 U.S.C. § 1114(s) at the housebound level was also restored.

The Board has remanded the claims of service connection for diabetes mellitus type II, prostate cancer, and skin cancer due to exposure to herbicide agents in Germany. The Veteran's lay statements and testimony regarding his claimed exposure will be reviewed, and VA examinations will determine if these conditions are related to service.